← back to search

Lori Lowe

University of Michigan–Ann Arbor · US
Area of research
Oncology · Epidemiology
Research interest
Research focused on Concordance and Melanoma, with related work in Dermatopathology, HRAS, Schema (genetic algorithms). Notable publications include 'Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions', 'Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from...', and 'Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of...'.
h-index
citations
112
works
3
NIH funding
primary concept
email

Recent publications

BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms
The American Journal of Surgical Pathology 2024cited by 12position: middledoi
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions
JAMA Network Open 2023cited by 63position: middledoi
Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee
Journal of Cutaneous Pathology 2021cited by 16position: middledoi
Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group
Journal of the American Academy of Dermatology 2016cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David E. Elder · California University of Pennsylvania2 papers (2016–2024)Christopher R. Shea · University of Illinois Chicago2 papers (2016–2024) · 2 papers (2016–2024)Raymond L. Barnhill · Sorbonne Paris Cité2 papers (2016–2024)Pedram Gerami · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2016–2024) · 2 papers (2016–2024)Richard A. Scolyer · Westmead Institute for Medical Research1 papers (2024–2024)Joost J. van den Oord · KU Leuven1 papers (2016–2016)Lisa M. Reisch · Dartmouth College1 papers (2016–2016) · 1 papers (2024–2024) · 1 papers (2016–2016)Douglas C. Parker · Emory University1 papers (2024–2024)Martin Cook · University of Manchester1 papers (2016–2016)George Xu · California University of Pennsylvania1 papers (2016–2016)Michael S. Rabkin · The University of Texas Health Science Center at Houston1 papers (2016–2016)Lyn M. Duncan · Medical University of South Carolina1 papers (2024–2024)Daniela Massi · University of Florence1 papers (2024–2024)Jane L. Messina · Moffitt Cancer Center1 papers (2016–2016)Stevan R. Knezevich · Seattle University1 papers (2016–2016)Willeke A.M. Blokx · Utrecht University1 papers (2024–2024)